Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM—a prospective, randomized, single-centre, open-label study-Reference-Cited by-同舟云学术

Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM—a prospective, randomized, single-centre, open-label study

Published:2022-06 Issue:6 Volume:28 Page:844-851
ISSN:1198-743X
Container-title:Clinical Microbiology and Infection
language:en
Short-container-title:Clinical Microbiology and Infection

Author:

Broman Niklas,Feuth Thijs,Vuorinen Tytti,Valtonen Mika,Hohenthal Ulla,Löyttyniemi Eliisa,Hirvioja Tiina,Jalava-Karvinen Päivi,Marttila Harri,Nordberg Marika,Oksi Jarmo

Funder

Turun Yliopisto

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference20 articles.

1. Imbalanced host response to SARS-CoV-2 drives development of COVID-19;Blanco-Melo;Cell,2020

2. IL-6 and other biomarkers as predictors of severity in COVID-19;Broman;Ann Med,2021

3. The role of C-reactive protein as a prognostic marker in COVID-19;Stringer;Int J Epidemiol,2021

4. Serum ferritin is an independent risk factor for acute respiratory distress syndrome in COVID-19;Gandini;J Infect,2020

5. Immunothrombotic dysregulation in COVID-19 pneumonia is associated with respiratory failure and coagulopathy;Nicolai;Circulation,2020

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The IL-6 hypothesis in COVID-19: A phase 2, randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of free IL-6 sequestration by the monoclonal antibody sirukumab in severe and critical COVID-19;Journal of Infection;2024-10

2. The effect of tocilizumab administration on inflammatory markers in COVID-19 patients;The Egyptian Journal of Bronchology;2024-08-17

3. Effect of tocilizumab plus corticosteroid on clinical outcome in patients hospitalized with severe fever with thrombocytopenia syndrome: A randomized clinical trial;Journal of Infection;2024-07

4. Clinical outcome and peripheral immune profile of myasthenic crisis with omicron infections: A prospective cohort study;Clinical Immunology;2024-02

5. Cytokine storm and translating IL-6 biology into effective treatments for COVID-19;Frontiers of Medicine;2023-12-29